Overview

Once Daily Immunosuppression Regimen

Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to determine whether an immunosuppressive maintenance regimen of Envarsus/azathioprine compared to a tacrolimus/ mycophenolic acid regimen is associated with better compliance, tolerability, and lower biopsy proven rejection.
Phase:
Phase 4
Details
Lead Sponsor:
Washington University School of Medicine
Collaborator:
Veloxis Pharmaceuticals